Contrary to the cancer context, we observed higher levels of PTEN in Sall2−/− cells (Supplementary Figure S9), which supports PTEN as an alternative or complementary mechanism in the Sall2-mediated FAK activation. This evidence concerns the gene PTK2 and cancer.